Back to search

Article

Adaptive anti-tumor immunity is orchestrated by a population of CCL5-producing tissue-resident NK cells

2021-05-27

Abstract excerpt

T cell-directed cancer immunotherapy often fails to generate lasting tumor control. Harnessing additional effectors of the immune response against tumors may strengthen the clinical benefit of immunotherapies. Here, we demonstrate that therapeutic targeting of the IFNγ-IL-12 pathway relies on the ability of a population of tissue-resident NK (trNK) cells to orchestrate an anti-tumor microenvironment. Particularly,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
76ab976e-1e9e-5be1-ae62-58097025d2dd
DOI
10.1101/2021.05.27.445981
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Adaptive anti-tumor immunity is orchestrated by a population of CCL5-producing tissue-resident NK cellsDOI 10.1101/2021.05.27.445981
Select a neighboring publication to make it the new centre.